Taken together, our findings show that IL-9 signaling is protective against obesity and insulin resistance and that IL-9 mediates its effects on glucose homeostasis and inflammation by inhibiting the NLRP3 inflammasome. Here, IL9 is linked to obesity due to melanocortin 4 receptor deficiency.